Literature DB >> 22478984

[Not Available].

Jean-François Bussières1, Mariève Simoncelli, Olivier Bourdon, Jean Lachaîne.   

Abstract

Year:  2010        PMID： 22478984      PMCID： PMC2901784          DOI： 10.4212/cjhp.v63i3.920

Source DB:  PubMed          Journal:  Can J Hosp Pharm        ISSN： 0008-4123


× No keyword cloud information.
  5 in total

1.  Access to new cardiovascular therapies in Canadian hospitals: a national survey of the formulary process.

Authors:  Stephen J Shalansky; Roohina Virk; Margaret Ackman; Cynthia Jackevicius; Heather Kertland; Ross Tsuyuki; Karin Humphries
Journal:  Can J Cardiol       Date:  2003-02       Impact factor: 5.223

2.  [Activity tarification and national guidelines for the proper use of expensive and innovative drugs in internal medicine].

Authors:  N Dumarcet
Journal:  Rev Med Interne       Date:  2007-06-21       Impact factor: 0.728

3.  A survey of Pharmacy and Therapeutic committees across Canada: scope and responsibilities.

Authors:  Nicole Mittmann; Sandra Knowles
Journal:  Can J Clin Pharmacol       Date:  2009-02-25

4.  Waiting for reimbursement of new medicines in Canada: it's time for a rethink.

Authors:  Brett J Skinner
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

5.  Activity-based hospital funding: boon or boondoggle?

Authors:  Roger Collier
Journal:  CMAJ       Date:  2008-05-20       Impact factor: 8.262
  5 in total
  1 in total

1.  [Not Available].

Authors:  Jean-François Bussières; Jennifer Corny; Olivier Bourdon
Journal:  Can J Hosp Pharm       Date:  2016-04-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.